Sang H. Seo

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model.

An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model.

Journal: Virus research
Published: July 06, 2026

Correction: Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Correction: Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Journal: Virology journal
Published: June 05, 2026

A PRNT-anchored OD-based micro-neutralization cytopathic effect assay for rapid screening of adenovirus neutralizing activity.

A PRNT-anchored OD-based micro-neutralization cytopathic effect assay for rapid screening of adenovirus neutralizing activity.

Journal: Diagnostic microbiology and infectious disease
Published: May 04, 2026

Development and analytical evaluation of a microneutralization cytopathic effect assay for human adenovirus type 55-specific neutralizing antibodies.

Development and analytical evaluation of a microneutralization cytopathic effect assay for human adenovirus type 55-specific neutralizing antibodies.

Journal: Journal of microbiology (Seoul, Korea)
Published: April 06, 2026

Advancements and challenges in next-generation mRNA vaccine manufacturing systems.

Advancements and challenges in next-generation mRNA vaccine manufacturing systems.

Journal: Clinical and experimental vaccine research
Published: July 25, 2025

Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55-Induced Respiratory Disease.

Establishment of a Cynomolgus Macaque Model for Human Adenovirus Type 55-Induced Respiratory Disease.

Journal: The Journal of infectious diseases
Published: May 15, 2025

Mouse strain-dependent neutralizing antibody responses to Zika virus vaccines.

Mouse strain-dependent neutralizing antibody responses to Zika virus vaccines.

Journal: Journal of microbiology (Seoul, Korea)
Published: April 04, 2025

Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.

Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.

Journal: mSphere
Published: December 26, 2024

Enhanced replication of a hepatitis A virus vaccine strain via adaptation in Vero cells.

Enhanced replication of a hepatitis A virus vaccine strain via adaptation in Vero cells.

Journal: Clinical and experimental vaccine research
Published: November 13, 2024

Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.

Journal: Virology journal
Published: August 07, 2024

One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.

One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 06, 2023

Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.

Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.

Journal: Scientific reports
Published: December 28, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026